Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
BMJ Case Reports|December 23, 2017
Uvular necrosis following diagnostic gastroscopyJonathan Digby-Bell, Sebastian ZekiBMJ Case Reports|March 7, 2018
Successful faecal microbiota transplant for recurrent Clostridium difficile infection delivered by colonoscopy through a diverted ileostomy in a patient with severe perianal Crohn's diseaseJonathan Digby-Bell, Andrew Williams, Peter Irving, et al.BMJ Case Reports|April 7, 2026
Organising pneumonia in ulcerative colitis with primary sclerosing cholangitis: drug-related toxicity or extraintestinal manifestation?Fakhirah Badrulhisham, Azad Kala Bhushan, Yousra Djouider, et al.Frontline Gastroenterology|August 26, 2017
Fragility fracture risk in cirrhosis: a comparison of the fracture risk assessment tool, British Society of Gastroenterology and National Institute for Health and Clinical Excellence guidelinesLachlan Richard Owen Ayres, Shane Clarke, Jonathan Digby-Bell, et al.Journal of Crohn'S & Colitis|July 24, 2021
The Reliability and Accuracy of Endoscopic Items and Scores Used in the Assessment of the Ileoanal Pouch and CuffZaid S Ardalan, Danny Con, Sujievvan Chandran, et al.Frontline Gastroenterology|July 27, 2018
Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Jonathan Digby-Bell, et al.Annals of Gastroenterology|March 5, 2020
Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experienceHajir Ibraheim, Mark A Samaan, Ashish Srinivasan, et al.Gut|December 4, 2019
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cellsNick Powell, Eirini Pantazi, Polychronis Pavlidis, et al.Nature Communications|October 3, 2022
Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapyPolychronis Pavlidis, Anastasia Tsakmaki, Eirini Pantazi, et al.Frontline Gastroenterology|August 26, 2017
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Emma Johnston, et al.Pageof 2